Investors Seek to Lead Class Action Against Metagenomi, Inc.

LOS ANGELES, Oct. 29, 2024 /PRNewswire/ — Glancy Prongay & Murray LLP (“GPM”) has announced that investors suffering significant losses have the opportunity to take the reins in a securities fraud class action lawsuit against Metagenomi, Inc. (“Metagenomi” or the “Company”) MGX.

Class Period: February 2024 IPO
Lead Plaintiff Deadline: November 25, 2024

Investors who wish to lead the Metagenomi lawsuit can submit their contact information at www.glancylaw.com/cases/Metagenomi-Inc/. For inquiries, contact Charles H. Linehan of GPM at 310-201-9150, toll-free at 888-773-9224, or email at shareholders@glancylaw.com to understand their rights.

The filed complaint claims that during the Class Period, the Defendants withheld vital information from investors, including: (1) the impending end of Metagenomi’s collaboration with Moderna and (2) that the Defendants’ favorable comments regarding the Company’s operations and future prospects were misleading and lacked a substantial basis.

Stay updated by following us on LinkedIn, Twitter, or Facebook.

To join the class action, no immediate action is required from you. You may choose to retain your own legal counsel or simply remain an absent member. For any questions regarding the class action or your rights, please reach out to Charles Linehan, Esquire at GPM, located at 1925 Century Park East, Suite 2100, Los Angeles, California 90067, or by phone at 310-201-9150, toll-free at 888-773-9224, or via email at shareholders@glancylaw.com. If emailing, please include your address, phone number, and number of shares purchased.

This press release may be considered Attorney Advertising in certain jurisdictions under the applicable laws and ethical standards.

Contacts
Glancy Prongay & Murray LLP, Los Angeles
Charles Linehan, 310-201-9150 or 888-773-9224
shareholders@glancylaw.com
www.glancylaw.com

View original content to download multimedia: here

SOURCE Glancy Prongay & Murray LLP